SKI Market

A+| A| A-|

Indian Indices

Sensex

76,034.42 -829.29
( -1.08%)

Global Indices

Nasdaq

47,431.94 -295.58
(-0.62%)

Dow Jones

6,795.43 -7.05
(-0.10%)

Hang Seng

54,230.47 -794.90
(-1.44%)

Nikkei 225

10,300.41 -53.36
(-0.52%)

Forex

USD-INR

91.90 -0.24
(-0.26%)

EUR-INR

106.87 0.29
(0.27%)

GBP-INR

123.51 0.42
(0.34%)

JPY-INR

0.58 0.00
(0.09%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Biogen Pharmachem Industries Ltd

Industry : Finance & Investments

BSE Code

ISIN Demat

Book Value()

531752

INE703D01023

1.0977251

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

20.33

55.06

EPS(TTM)

Face Value()

Div & Yield %

0.03

Back

trident ltd

NCL Research and Financial Services reports standalone net profit of Rs 0.41 crore in the December 2025 quarter

Feb 06,2026

Net profit of NCL Research and Financial Services reported to Rs 0.41 crore in the quarter ended December 2025 as against net loss of Rs 0.38 crore during the previous quarter ended December 2024. Sales declined 41.64% to Rs 2.13 crore in the quarter ended December 2025 as against Rs 3.65 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	2.13	3.65	-42
OPM %	27.23	23.84	-
PBDT	0.58	-0.33	LP
PBT	0.57	-0.35	LP
NP	0.41	-0.38	LP

76,034.42 -829.29 ( -1.08%)

47,431.94 -295.58 (-0.62%)

6,795.43 -7.05 (-0.10%)

54,230.47 -794.90 (-1.44%)

10,300.41 -53.36 (-0.52%)

91.90 -0.24 (-0.26%)

106.87 0.29 (0.27%)

123.51 0.42 (0.34%)

0.58 0.00 (0.09%)